(Q41508287)

English

Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil

scientific article published on September 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil (English)

1 reference

10.1007/BF01645369

https://api.crossref.org/works/10.1007/BF01645369

28 November 2022

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A. Bauernfeind

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1800377

28 November 2022

R. Jungwirth

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1800377

28 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1800377

28 November 2022

publication date

1 September 1991

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF01645369.pdf

Portable Document Format

1 reference

10.1007/BF01645369

https://api.crossref.org/works/10.1007/BF01645369

28 November 2022

http://link.springer.com/article/10.1007/BF01645369/fulltext.html

1 reference

10.1007/BF01645369

https://api.crossref.org/works/10.1007/BF01645369

28 November 2022

http://link.springer.com/content/pdf/10.1007/BF01645369

1 reference

10.1007/BF01645369

https://api.crossref.org/works/10.1007/BF01645369

28 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

353-362

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae

1 reference

https://pubmed.ncbi.nlm.nih.gov/1800377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1800377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection of antibiotics for treatment and prophylaxis of staphylococcal infections in cystic fibrosis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1800377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of cefetamet (Ro 15-8074)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1800377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/1800377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefaclor: in vitro spectrum of activity and beta-lactamase stability

1 reference

https://pubmed.ncbi.nlm.nih.gov/1800377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacteriological in vitro investigations with cefaclor. Correlation of inhibition zone diameter and minimal inhibitory concentration (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1800377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to six new oral cephalosporins

1 reference

https://pubmed.ncbi.nlm.nih.gov/1800377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01645369

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41508287&oldid=2204590707"